Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts
- PMID: 17381549
- PMCID: PMC2225626
- DOI: 10.1111/j.1474-9726.2007.00288.x
Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts
Abstract
Dyskeratosis congenita (DC), an inherited bone marrow failure syndrome, is caused by defects in telomerase. Somatic cells from DC patients have shortened telomeres and clinical symptoms are most pronounced in organs with a high cell turnover, including those involved in hematopoiesis and skin function. We previously identified an autosomal dominant (AD) form of DC that is caused by mutations in the telomerase RNA component (TER). In this study, we evaluated whether retroviral expression of TER and/or telomerase reverse transcriptase (TERT), the catalytic component of telomerase, could extend telomere length and rescue AD DC cells from a phenotype characteristic of early senescence. Exogenous TER expression, without TERT, could not activate telomerase in AD DC skin fibroblasts. Transduction of TERT alone, however, provided AD DC cells with sufficient telomerase activity to extend average telomere length and proliferative capacity. Interestingly, we found that expression of TER and TERT together resulted in extension of lifespan and higher levels of telomerase and longer telomeres than expression of TERT alone in both AD DC and normal cells. Our results provide evidence that AD DC cells can be rescued from defects in telomere maintenance and proliferation, and that coexpression of TERT and TER together provides a more efficient means to elongate telomeres than expression of TERT alone. Similar strategies may be useful for ameliorating the detrimental effects of telomere shortening in AD DC and other diseases associated with telomerase or telomere defects.
Figures








Similar articles
-
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.Exp Dermatol. 2010 Mar;19(3):279-88. doi: 10.1111/j.1600-0625.2009.00916.x. Epub 2009 Jun 23. Exp Dermatol. 2010. PMID: 19558498 Free PMC article.
-
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.Hum Mol Genet. 2012 Feb 15;21(4):721-9. doi: 10.1093/hmg/ddr504. Epub 2011 Nov 4. Hum Mol Genet. 2012. PMID: 22058290 Free PMC article.
-
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.Genes Dev. 2006 Oct 15;20(20):2848-58. doi: 10.1101/gad.1476206. Epub 2006 Oct 2. Genes Dev. 2006. PMID: 17015423 Free PMC article.
-
Dyskeratosis congenita: a disorder of defective telomere maintenance?Int J Hematol. 2005 Oct;82(3):184-9. doi: 10.1532/IJH97.05067. Int J Hematol. 2005. PMID: 16207588 Review.
-
Dyskeratosis congenita: telomerase, telomeres and anticipation.Curr Opin Genet Dev. 2005 Jun;15(3):249-57. doi: 10.1016/j.gde.2005.04.004. Curr Opin Genet Dev. 2005. PMID: 15917199 Review.
Cited by
-
Nuclear export restricts Gdown1 to a mitotic function.Nucleic Acids Res. 2022 Feb 28;50(4):1908-1926. doi: 10.1093/nar/gkac015. Nucleic Acids Res. 2022. PMID: 35048979 Free PMC article.
-
The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.Antioxid Redox Signal. 2011 Mar 15;14(6):985-97. doi: 10.1089/ars.2010.3444. Epub 2011 Jan 17. Antioxid Redox Signal. 2011. PMID: 21087144 Free PMC article.
-
Effect of gait training using rhythmic auditory stimulation on gait speed in older adults admitted to convalescent rehabilitation wards: A study protocol for a pilot randomized controlled clinical trial.Contemp Clin Trials Commun. 2023 Apr 1;33:101125. doi: 10.1016/j.conctc.2023.101125. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37091510 Free PMC article.
-
Pathogenic TERT promoter variants in telomere diseases.Genet Med. 2019 Jul;21(7):1594-1602. doi: 10.1038/s41436-018-0385-x. Epub 2018 Dec 7. Genet Med. 2019. PMID: 30523342 Free PMC article.
-
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.Exp Dermatol. 2010 Mar;19(3):279-88. doi: 10.1111/j.1600-0625.2009.00916.x. Epub 2009 Jun 23. Exp Dermatol. 2010. PMID: 19558498 Free PMC article.
References
-
- Allsopp RC, Chang E, Kashefiaazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res. 1995;220:194–200. - PubMed
-
- Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005;102:15960–15964. - PMC - PubMed
-
- Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47:89–99. - PubMed
-
- Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6:611–622. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources